Products

Image description

FDA approves Striverdi Respimat spray to treat COPD

The Food and Drug Administration approved Striverdi Respimat (olodaterol) inhalation spray for the treatment of chronic obstructive pulmonary disease, including chronic bronchitis and/or emphysema that are experiencing airflow obstruction, the agency announced.